Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

✍ Scribed by Herbert D. Aronow; Steven R. Steinhubl; Danielle M. Brennan; Peter B. Berger; Eric J. Topol

• Book ID: 116191600
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 181 KB
• Volume: 157
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2008.09.011